Protecting America from Seasonal and Pandemic Influenza Act of 2023

The Protecting America from Seasonal and Pandemic Influenza Act of 2023 establishes national goals to improve influenza preparedness and response, including delivering first doses of influenza vaccine within 12 weeks of a pandemic strain's emergence and developing a universal vaccine within 10 years. The bill authorizes $335 million annually for pandemic influenza activities, strengthens vaccine supply chains through public-private partnerships, and requires the development of rapid at-home diagnostic tests to improve access. It specifically focuses on addressing vaccine hesitancy through community partnerships targeting vulnerable populations including racial and ethnic minorities, seniors, and people with chronic conditions. The legislation mandates annual reports on implementation progress and requires incorporating health equity into influenza planning and response efforts. This comprehensive approach aims to build a more resilient system for preventing and responding to both seasonal and pandemic influenza.